Novavax Names John C. Jacobs as New President & Chief Executive Officer

Published on :

Novavax Names John C. Jacobs as New President & Chief Executive Officer
Jan 9, 2023
Current President & CEO Stanley C. Erck will retire effective January 23 with plans to support the leadership transition in an advisory capacity
Novavax is well-positioned to execute on its strategy, with global authorizations for its COVID-19 vaccine and continued clinical pipeline development
GAITHERSBURG, Md., Jan. 9, 2023 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that John C. Jacobs will succeed Stanley C. Erck as President and Chief Executive Officer and a member of the Board of Directors. The transition will be effective as of January 23, 2023. Mr. Erck will serve as an advisor to the Company for the next fifteen months to enable a smooth transition.
“As we prepare for Stan’s retirement, the Board reflects on the incredible legacy he leaves behind,” said James F. Young, PhD, Chairman of the Board of Directors. “Stan led Novavax from a clinical development organization to a global commercial vaccines company during a worldwide pandemic. This foundation puts Novavax in a strong position to execute on its long-term strategy, and we look…

Conexus Solutions, Inc. Announces Addition of Fred Halperin as Vice President, Commercial

Published on :

Halperin brings over 35 years of pharmaceutical industry experience to the newly created role. Prior to joining Conexus, he held several senior practice leadership roles at Accenture, Tata Consulting Services, etc., as well as in the Technology function at companies such as Johnson & Johnson, Merck, and Otsuka Pharmaceuticals. Most recently, he established and led the internal IT function for a bio-pharmaceutical start-up where he was responsible for implementing a new technology infrastructure and application portfolio to support the Commercial, R&D, and Corporate Support functions within the company.

Sartorius Names Maurice Phelan as New President for North America

Published on :

Sartorius, a leading international partner of life science research and the biopharmaceutical industry, announces Maurice Phelan has assumed the role of President of Sartorius North America. He succeeds Mary Lavin, who has retired after nearly 35 years. Sartorius North America, headquartered in Bohemia, New York, currently employs more than 3,000 employees across 17 sites in the United States and Canada.

SciNeuro Pharmaceuticals Announces the Appointment of Guojun Bu, Ph.D., as Chief Scientific Officer, and Provides Update on Pipeline of Novel CNS Therapeutics

Published on :

Dr. Bu joins SciNeuro with more than 30 years’ experience in neurodegenerative disease research, therapeutic discovery, and translation, most recently as Chair of the Department of Neuroscience, Mayo Clinic. He will have overall leadership responsibility for SciNeuro’s discovery and preclinical research activities, based in Rockville, MD, and will drive the translation of SciNeuro’s R&D pipeline programs.

In Conversation: Kelly Schulz, CEO, Maryland Tech Council

Maryland Tech Council
Published on :

The Maryland Tech Council (MTC) is the largest support organization for technology and life sciences companies in the state. MTC creates and supports initiatives, from events to workforce development, that bring the entire Maryland tech and life sciences ecosystem together to advance innovation and foster growth.

Conexus Solutions Appoints Jim Rondinone as Director of Client Services

Published on :

As a Director of Client Services, Jim Rondinone’s role is to lead a team of Program Managers who oversee our service delivery to the Company’s customers. He will help ensure that Conexus’ Program Managers continue to grow and develop their skills to become more effective in their role, thereby increasing the value of the company’s deliverables and ultimately strengthening the relationships that the team has with their customers. 

Anshika Jain, Ph.D., Joins American Gene Technologies® as Principal Scientist

Published on :

In this role, Dr. Jain will lead the translational studies for the American Gene™ HIV cure clinical trial, developing scientific plans and overseeing the research. Specifically, she will be responsible for identifying the biomarkers, developing and validating assays, managing vendors for outsourced projects, analyzing the scientific data, and working with the team to understand the patient data and the clinical outcome of the HIV trials.

CraniUS Appoints World Leading Johns Hopkins Neurosurgeon Dr. Henry Brem to Join Board of Directors

Published on :

CraniUS Appoints World Leading Neurosurgeon to Join Board of Directors

Dr. Henry Brem joins CraniUS Board of Directors in further enhancing its mission to facilitate chronic and direct medicine delivery for treating brain disease.

Olatilewa Komolafe Joins American Gene Technologies® as Marketing & Social Media Specialist

Published on :

Olatilewa was hired as a Sales and Marketing Specialist for the COVID Business Unit at American Gene Technologies®, where she was responsible for enlisting doctors and medical facilities to partner with American Gene’s COVID lab, which helps fund the American Gene™ HIV cure program. She recently transitioned into the Marketing Department, accepting the position of Marketing and Social Media Specialist, where her responsibilities include: